Feds Face Down Mallinckrodt in Acthar Whistleblower Lawsuits

Drug Industry Daily
The Department of Justice has entered the legal battle against Mallinckrodt over HP Acthar gel, joining a pair of whistleblower lawsuits that allege a company the drugmaker acquired bribed doctors to push the drug among other unlawful tactics.

To View This Article:


Subscribe To Drug Industry Daily